Skip to main content

Advertisement

Log in

Epithelial-Mesenchymal Transition Induced by Hepatitis C Virus Core Protein in Cholangiocarcinoma

  • Translational Research and Biomarkers
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Cholangiocarcinoma (CC) is associated with chronic hepatitis C virus (HCV) infection. We investigated the effect of hepatitis C virus core protein (HCVc) on epithelial-mesenchymal transition (EMT) in CC and tried to identify its target trigger.

Methods

First, we examined expression of HCVc and epithelial and mesenchymal markers in CC tissues. Then we transient-transfected HCVc gene into a CC cell line and examined expression of lysyl oxidase-like 2 (LOXL2) and epithelial and mesenchymal markers by quantitative real-time polymerase chain reaction (PCR) and Western blotting. Finally, LOXL2 gene silencing was shown in QBC939/HCVc cells by RNA interference (RNAi), and we further examined expression of epithelial and mesenchymal markers by quantitative real-time PCR and Western blotting.

Results

Through immunohistochemical staining, the present study showed that HCVc is significantly associated with CC invasion and metastasis. In vitro study showed that HCVc expression induces EMT in CC cell line QBC939, and a mechanism through LOXL2 pathway is suggested. Expression of HCVc was significantly correlated with greater migratory and invasive potential of CC cells.

Conclusions

These observations indicate that HCVc plays a critical role in promoting invasion and metastasis of CC cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol. 2002;17:1049–55.

    Article  PubMed  Google Scholar 

  2. Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, et al. Incidence of primary cholangiocelluar carcinoma of the liver in Japanese patients with HCV-related cirrhosis. Cancer. 2000;88:2471–7.

    Article  CAS  PubMed  Google Scholar 

  3. Sato Y, Kato J, Takimoto R, Takada K, Kawano Y, Miyanishi K, et al. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor a expression via activation of nuclear factor-kB. Gut. 2006;55:1801–8.

    Article  CAS  PubMed  Google Scholar 

  4. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431–6.

    Article  CAS  PubMed  Google Scholar 

  5. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415–28.

    Article  CAS  PubMed  Google Scholar 

  6. Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76–83.

    Article  CAS  PubMed  Google Scholar 

  7. Kang Y, Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004;118:277–9.

    Article  CAS  PubMed  Google Scholar 

  8. Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, Pehamberger H, et al. NF-kB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest. 2004;114:569–81.

    CAS  PubMed  Google Scholar 

  9. Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol. 2005;168:29–33.

    Article  CAS  PubMed  Google Scholar 

  10. Csiszar K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol. 2001;70:1–32.

    Article  CAS  PubMed  Google Scholar 

  11. Gao YH, Li TY, Gao ZF, Jiang WW, Wang SG. Expression of LOXL2 protein in cholangiocarcinoma tissuses and relation with EMT. Zhonghua Pu Tong Wai Ke Za Zhi. 2008;23:794–7.

    Google Scholar 

  12. Richmond PJM, Karayiannakis AJ, Nagafuchi A, Kaisary AV, Pignatelli M. Aberrant E-cadherin and α-catenin expression in prostate cancer: correlation with patient survival. Cancer Res. 1997;57:3189–93.

    CAS  PubMed  Google Scholar 

  13. Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, et al. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res. 2004;10:4125–33.

    Article  CAS  PubMed  Google Scholar 

  14. Wang SG, Han BL, Duan HC, Chen YS, Peng ZM. Establishment of a cell line of extrahepatic bile duct carcinoma. Zhonghua Shi Yan Wai Ke Za Zhi. 1997;14:67–8.

    CAS  Google Scholar 

  15. Zvaifler NJ. Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases. Arthritis Res Ther. 2006;8:210.

    Article  PubMed  Google Scholar 

  16. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer. 2004;4:448–56.

    Article  CAS  PubMed  Google Scholar 

  17. Lan M, Kojima T, Osanai M, Chiba H, Sawada N. Oncogenic Raf-1 regulates epithelial to mesenchymal transition via distinct signal transduction pathways in an immortalized mouse hepatic cell line. Carcinogenesis. 2004;25:2385–95.

    Article  CAS  PubMed  Google Scholar 

  18. Gotzmann J, Huber H, Thallinger C, Wolschek M, Jansen B, Schulte-Hermann R, et al. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. J Cell Sci. 2002;115:1189–202.

    CAS  PubMed  Google Scholar 

  19. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442–54.

    Article  CAS  PubMed  Google Scholar 

  20. Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol. 2006;37:1211–6.

    Article  CAS  PubMed  Google Scholar 

  21. Lu H, Ye MQ, Thung SN, Dash S, Gerber MA. Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients. Chin Med J (Engl). 2000;113:1138–41.

    CAS  Google Scholar 

  22. Yin F, Chen B. Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction. Chin Med J (Engl). 1998;111:1068–70.

    CAS  Google Scholar 

  23. Liu XF, Zou SQ, Qiu FZ. Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus. Hepatobiliary Pancreat Dis Int. 2003;2:285–9.

    PubMed  Google Scholar 

  24. Chen Rf, Li ZH, Chen JS, Zou SQ. Hepatitis C virus core protein modulating proliferation and apoptosis of hilar cholangiocarcinoma tissues. Zhonghua Shi Yan Wai Ke Za Zhi. 2002;19:510–1.

    Google Scholar 

  25. Grimstad IA. Direct evidence that cancer cell locomotion contributes importantly to invasion. Exp Cell Res. 1987;173:515–3.

    Article  CAS  PubMed  Google Scholar 

  26. Peinado H, Del Carmen Iglesias-de la Cruz M, Olmeda D, Csiszar K, Fong KS, Vega S, et al. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J. 2005;19:3446–58.

    Article  Google Scholar 

  27. Peinado H, Moreno-Bueno G, Hardisson D, Pérez-Gómez E, Santos V, Mendiola M, et al. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas. Cancer Res. 2008;68:4541–50.

    Article  CAS  PubMed  Google Scholar 

  28. Hohenester E, Sasaki T, Timpl R. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nat Struct Biol. 1999;6:228–32.

    Article  CAS  PubMed  Google Scholar 

  29. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 2002;21:5017–25.

    Article  CAS  PubMed  Google Scholar 

  30. Barth H, Schnober EK, Neumann-Haefelin C, Thumann C, Zeisel MB, Diepolder HM, et al. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J Virol. 2008;82:3466–79.

    Article  CAS  PubMed  Google Scholar 

  31. Jia ZS, Du DW, Lei YF, Wei X, Yin W, Ma L, et al. Scavenger receptor class B type I mediates cell entry of hepatitis C virus. J Int Med Res. 2008;36:1319–25.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgment

We acknowledge grant (30872496) from National Nature Science Foundation of China and grant CSTC 2008BB5126 from the Natural Science Foundation of ChongQing. The authors would also like to thank Dr. Yan Hwa Wu Lee (National Yang-Ming University in Taiwan) for provision of recombinant plasmid containing HCVc gene, PGST-HCVc195.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuguang Wang PhD.

Additional information

Tianyu Li and Dajiang Li contributed equally to this paper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, T., Li, D., Cheng, L. et al. Epithelial-Mesenchymal Transition Induced by Hepatitis C Virus Core Protein in Cholangiocarcinoma. Ann Surg Oncol 17, 1937–1944 (2010). https://doi.org/10.1245/s10434-010-0925-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-0925-3

Keywords

Navigation